Notice of Intent to Publish a Funding Opportunity Announcement for Single Source for Continuation of the Environmental Determinants of Diabetes in The Young Study (TEDDY) Data Coordinating Center (U01
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Jul 16, 2026
Can you apply?
This grant is for a single-source continuation award to fund the Environmental Determinants of Diabetes in the Young (TEDDY) study Data Coordinating Center (DCC). This is a non-competitive award specifically designated for University of South Florida to continue ongoing epidemiological research and data management activities.
The DCC will complete analysis of samples from a second case-control cohort and manage study closeout activities. The project involves data management, biosampling, and cohort analysis related to type 1 diabetes prevention and treatment research.
This is a highly specialized research continuation award associated with the Special Diabetes Program, supporting collaborative epidemiological research on type 1 diabetes determinants in youth populations.
Not the right fit? Find grants for your organization in 5 questions →
Key dates
- May 12, 2025 Applications open
- Oct 26, 2025 Application deadline
- Jun 1, 2026 Award announced
- Jul 1, 2026 Project start
Program description
This is a non-competitive funding opportunity intended to fund a single award. The National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) is announcing its intent to issue a single source cooperative agreement award to University of South Florida for of the current Data Coordinating Center (DCC) for The Environmental Determinants of Diabetes in the Young (TEDDY) study, an ongoing epidemiological study. This DCC has been involved in study design and data and bio sample acquisition and management since the inception of the TEDDY Consortium. The DCC has initiated a second case-control analysis of the TEDDY cohort. This NOFO provides support for the TEDDY DCC to continue to complete the ongoing analysis of the samples from the second case control cohort and allow funding for closeout of the study. This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.
Who can apply
Eligible applicants
- 501(c)(3) Public Charity
- City / Municipal Government
- County Government
- Nonprofits
- Private University
- Public Authority
- Public K-12 School
- Public University
- Small Business (SBA-defined)
- Special District
- State Government
- Tribal Nation
- Tribal Organization
Demographic focus
How to apply
Application links
Key dates & requirements
Required documents
- Grant application (specific format per NIH NOFO requirements)
- Budget and budget narrative
- Project narrative
- Institutional commitment letters
- Data management and security plan
- Timeline for analysis completion and study closeout
- Curriculum vitae of key personnel
- Institutional biosafety certifications (if applicable)
Program contact
- 👤 Arthur Castle, Ph.D. National Institute of Diabetes and Digestive and Kidney Diseases
- 📧 castlea@niddk.nih.gov
- 📞 301-594-7719
Funding track record
Recent awards under CFDA 93.855 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$246,626,852
-
$201,437,825
-
$185,816,804
-
$180,737,624
-
$136,265,880
-
$116,817,868
-
$93,394,862
-
$89,845,851
-
$74,456,241
-
$72,987,380
Top States by Funding
- CA 8 awards $696.2M
- MA 6 awards $602.8M
- NY 6 awards $335.0M
- TX 3 awards $280.9M
- GA 5 awards $257.9M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
Funding history
Annual funding for this program — Federal obligations (CFDA 93.855). How funding has trended year over year.
| 2024 | $4,073,812,529 | |
| 2025 | $4,378,235,639 | |
| 2026 est. | $4,299,426,996 |
FAQ
Who is eligible to apply for this grant?
This is a single-source, non-competitive award designated specifically for University of South Florida. The grant supports continuation of the existing TEDDY Data Coordinating Center operations.
What is the funding amount?
The award is approximately $6,000,000 for the continuation and closeout of the TEDDY study.
What activities does this funding support?
The DCC will continue data and biosampling management, complete analysis of the second case-control cohort, and execute study closeout procedures.
Is cost sharing required?
No cost sharing or matching funds are required for this cooperative agreement award.
What is the application deadline?
The deadline is October 26, 2025. This is a single-source award, so standard competitive application processes do not apply.
💡 Tips for applicants
- Single-source awards are non-competitive and designated for specific awardees. This opportunity applies only to University of South Florida as the incumbent DCC.
- Understand the distinction between data coordination activities and primary research. The DCC role emphasizes data management, biosampling, and administrative functions.
- Review the Special Diabetes Program guidance to align your proposal with type 1 diabetes prevention and treatment research priorities and consortium expectations.
- Focus on detailed timelines and resource allocation for the second case-control analysis and the structured study closeout process.
- Familiarize yourself with NIH cooperative agreement requirements, which involve substantial agency involvement in the award beyond standard grants.
⚠️ Common mistakes
Misunderstanding this as an open, competitive funding opportunity when it is a single-source award. Submitting an application as an institution other than the designated recipient.
Underestimating the administrative and compliance burden of managing study closeout activities alongside ongoing analysis. Not clearly delineating phases: continued analysis, final reporting, and formal closeout procedures.
Failing to address how the DCC will maintain data quality and participant confidentiality through final closeout and archiving.
Similar grants
- OPEN Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed) — National Institutes of Health
- CLOSED Forecast to Publish a Notice of Funding Opportunity Announcement for Addressing Determinants of Health Disparities Among Rural Populations (R01 – Clinical Trial Optional) — National Institutes of Health
- CLOSED Forecast to Renew the Funding Opportunity Announcement for Multiple Chronic Disease Research Centers Coordinating Center (U24 Clinical Trial Not Required) — National Institutes of Health
- CLOSED Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed) — National Institutes of Health
- CLOSED Single Source for Establishing Pilot/Opportunity program for AI Models to Accelerate Diabetes Research (U24- Clinical Trials not allowed) — National Institutes of Health